Eniola should apply to the EV Africa & Caribbean track (selecting 'Africa' in the Affected Region field) with the CCT model framed as the centrepiece of a canonical talent-unlocking story: a sole-authored tripartite pharmacological framework for addiction prevention, computationally validated from Lagos with no institutional backing, that has already attracted public endorsements from Berridge (Michigan), Gershman (Harvard), Daw (Princeton), and Mattar (NYU) — four of the top labs in reward neuroscience. The personal story section should trace the arc from clinical pharmacy in Nigeria to independent computational neuroscience, emphasising how the lack of institutional access forced a more rigorous, first-principles approach. For the 'mainstream view' question, she should answer something like 'addiction is fundamentally a disorder of memory encoding, not just reward' — stating the NIDA/neuroscience consensus position that she then extends rather than overturns, showing she understands the field deeply enough to know what is settled versus what her model adds. The pitch should ask for a concrete, small-to-mid ask (e.g. $15K–$25K) tied to a specific next step: compute time for full Bayesian MCMC parameter sweep, travel to present at a US neuroscience conference to accelerate collaborator relationships, or seed funding for IMPRINT's clinical validation pilot — framing the grant as the bridge between three preprints and a provisionally patented architecture already drawing elite endorsements, and a first wet-lab or clinical partnership.